Home Newsletters Cancer Stem Cell News MiR-199 Reverses the Resistance to Gemcitabine in Pancreatic Cancer by Suppressing Stemness...

MiR-199 Reverses the Resistance to Gemcitabine in Pancreatic Cancer by Suppressing Stemness through Regulating the Epithelial–Mesenchymal Transition

By
Justin.choi
-
0
Researchers investigate the function of miR-199 on gemcitabine-resistance in pancreatic cancer, as well as the underlying mechanism.
[ACS Omega]

Sorry, but the selected Zotpress account can't be found.

Full ArticleGraphical Abstract

RELATED ARTICLES

Exit mobile version